173 related articles for article (PubMed ID: 1730510)
1. Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA).
Larsson R; Kristensen J; Sandberg C; Nygren P
Int J Cancer; 1992 Jan; 50(2):177-85. PubMed ID: 1730510
[TBL] [Abstract][Full Text] [Related]
2. In vitro analysis of drug resistance in tumor cells from patients with acute myelocytic leukemia.
Kristensen J; Jonsson B; Sundström C; Nygren P; Larsson R
Med Oncol Tumor Pharmacother; 1992; 9(2):65-74. PubMed ID: 1341718
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of the fluorometric microculture cytotoxicity assay (FMCA) for cytotoxic drug sensitivity testing of tumor cells from patients with acute lymphoblastic leukemia.
Nygren P; Kristensen J; Jonsson B; Sundström C; Lönnerholm G; Kreuger A; Larsson R
Leukemia; 1992 Nov; 6(11):1121-8. PubMed ID: 1434793
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapeutic drug sensitivity testing of human leukemia cells in vitro using a semiautomated fluorometric assay.
Larsson R; Nygren P; Ekberg M; Slater L
Leukemia; 1990 Aug; 4(8):567-71. PubMed ID: 2388483
[TBL] [Abstract][Full Text] [Related]
5. Detection of tumor-specific cytotoxic drug activity in vitro using the fluorometric microculture cytotoxicity assay and primary cultures of tumor cells from patients.
Nygren P; Fridborg H; Csoka K; Sundström C; de la Torre M; Kristensen J; Bergh J; Hagberg H; Glimelius B; Rastad J
Int J Cancer; 1994 Mar; 56(5):715-20. PubMed ID: 8314348
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic drug sensitivity testing of tumor cells from patients with ovarian carcinoma using the fluorometric microculture cytotoxicity assay (FMCA).
Csoka K; Larsson R; Tholander B; Gerdin E; de la Torre M; Nygren P
Gynecol Oncol; 1994 Aug; 54(2):163-70. PubMed ID: 7520407
[TBL] [Abstract][Full Text] [Related]
7. In vitro drug resistance in B cell chronic lymphocytic leukemia: a comparison with acute myelocytic and acute lymphocytic leukemia.
Aleskog A; Larsson R; Höglund M; Kristensen J; Nygren P; Lindhagen E
Anticancer Drugs; 2005 Mar; 16(3):277-83. PubMed ID: 15711179
[TBL] [Abstract][Full Text] [Related]
8. Interactions between cladribine (2-chlorodeoxyadenosine) and standard antileukemic drugs in primary cultures of human tumor cells from patients with acute myelocytic leukemia.
Kristensen J; Nygren P; Liliemark J; Fridborg H; Killander A; Simonsson B; Oberg G; Larsson R
Leukemia; 1994 Oct; 8(10):1712-7. PubMed ID: 7934168
[TBL] [Abstract][Full Text] [Related]
9. In vitro determination of cytotoxic drug response in ovarian carcinoma using the fluorometric microculture cytotoxicity assay (FMCA).
Csóka K; Tholander B; Gerdin E; de la Torre M; Larsson R; Nygren P
Int J Cancer; 1997 Sep; 72(6):1008-12. PubMed ID: 9378534
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological modification of multi-drug resistance (MDR) in vitro detected by a novel fluorometric microculture cytotoxicity assay. Reversal of resistance and selective cytotoxic actions of cyclosporin A and verapamil on MDR leukemia T-cells.
Larsson R; Nygren P
Int J Cancer; 1990 Jul; 46(1):67-72. PubMed ID: 2194983
[TBL] [Abstract][Full Text] [Related]
11. Combination screening in vitro identifies synergistically acting KP372-1 and cytarabine against acute myeloid leukemia.
Österroos A; Kashif M; Haglund C; Blom K; Höglund M; Andersson C; Gustafsson MG; Eriksson A; Larsson R
Biochem Pharmacol; 2016 Oct; 118():40-49. PubMed ID: 27565890
[TBL] [Abstract][Full Text] [Related]
12. In vitro drug sensitivity testing of tumor cells from patients with non-Hodgkin's lymphoma using the fluorometric microculture cytotoxicity assay.
Nygren P; Hagberg H; Glimelius B; Sundström C; Kristensen J; Christiansen I; Larsson R
Ann Oncol; 1994; 5 Suppl 1():127-31. PubMed ID: 8172809
[TBL] [Abstract][Full Text] [Related]
13. The fluorometric microculture cytotoxicity assay.
Lindhagen E; Nygren P; Larsson R
Nat Protoc; 2008; 3(8):1364-9. PubMed ID: 18714304
[TBL] [Abstract][Full Text] [Related]
14. In vitro testing of chemotherapeutic drug combinations in acute myelocytic leukaemia using the fluorometric microculture cytotoxicity assay (FMCA).
Larsson R; Fridborg H; Kristensen J; Sundström C; Nygren P
Br J Cancer; 1993 May; 67(5):969-74. PubMed ID: 8494730
[TBL] [Abstract][Full Text] [Related]
15. In vitro activity of 2-chlorodeoxyadenosine (CdA) in primary cultures of human haematological and solid tumours.
Larsson R; Fridborg H; Liliemark J; Csoka K; Kristensen J; de la Torre M; Nygren P
Eur J Cancer; 1994; 30A(7):1022-6. PubMed ID: 7946567
[TBL] [Abstract][Full Text] [Related]
16. Activity of cyclosporins as resistance modifiers in primary cultures of human haematological and solid tumours.
Fridborg H; Jonsson B; Nygren P; Csoka K; Nilsson K; Oberg G; Kristensen J; Bergh J; Tholander B; Olsen L
Br J Cancer; 1994 Jul; 70(1):11-7. PubMed ID: 8018519
[TBL] [Abstract][Full Text] [Related]
17. Use of the microculture kinetic assay of apoptosis to determine chemosensitivities of leukemias.
Kravtsov VD; Greer JP; Whitlock JA; Koury MJ
Blood; 1998 Aug; 92(3):968-80. PubMed ID: 9680366
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of in vitro assessment of cytotoxic drug activity in advanced breast cancer.
Villman K; Blomqvist C; Larsson R; Nygren P
Anticancer Drugs; 2005 Jul; 16(6):609-15. PubMed ID: 15930887
[TBL] [Abstract][Full Text] [Related]
19. In vitro cytotoxic drug activity and in vivo pharmacokinetics in childhood acute myeloid leukemia.
Lönnerholm G; Frost BM; Larsson R; Liliemark E; Nygren P; Peterson C
Adv Exp Med Biol; 1999; 457():429-35. PubMed ID: 10500819
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of purine and pyrimidine analogues in human tumor cells from patients with low-grade lymphoproliferative disorders using the FMCA.
Aleskog A; Larsson R; Höglund M; Sundström C; Kristensen J
Eur J Haematol; 1999 May; 62(5):293-9. PubMed ID: 10359056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
